Login to Your Account



Servier, SIMM Set to Collaborate on Targeted Drug for Breast Cancer

By Shannon Ellis
Staff Writer

Friday, October 4, 2013
SHANGHAI – A well-established French biotech company is working with one of China’s most authoritative state drug discovery organizations to develop a drug that could help the country tackle the growing incidence of breast cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription